Panbela Therapeutics, Inc. (NASDAQ: PBLA) reported Q1 EPS of ($2.28), $1.32 better than the analyst estimate of ($3.60).

For earnings history and earnings-related data on Panbela Therapeutics, Inc. (PBLA) click here.